Announced Sun, 31 May · 10:09 IST

Newspaper publication of Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2026

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-8.0%1-day move
₹30.10
prior close
₹30.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-2.0-0.8-1.2-8.0-10.0-8.1-7.5-8.7-5.6+13.0+23.2
Up moveDown movePending
AI summary

Pharmaids Pharmaceuticals Ltd has disclosed the publication of its audited financial results for Q4 FY2026 and the full year ended March 31, 2026. The results were published as newspaper advertisements on May 31, 2026 in two publications: Financial Express (English newspaper with nationwide circulation) and Hosa Digantha (Kannada vernacular newspaper). This disclosure complies with SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, specifically Regulations 30 and 47 which mandate publication of financial results in newspapers. The company has also made this information available on its website at www.pharmaids.com. The filing confirms the company's regulatory compliance for quarterly and annual financial reporting.

Likely market impact

This filing confirms that Pharmaids Pharmaceuticals has published its audited annual financial results, making it available publicly. For shareholders, this represents the completion of the formal annual reporting process for FY2026, with results now accessible through newspapers and the company's website.